Skip to main content
. 2021 Oct 18;18(4):2664–2681. doi: 10.1007/s13311-021-01140-4

Table 2.

Mortality % observed in the different treatment groups during the 5-week CUS protocol

Group Mortality (%)
Control 0
CUS 15.4
CUS + Escita 0
CUS + Dapa 0
CUS + B + Dapa 15.4

B BQ-788, CUS chronic unpredictable stress, Dapa dapagliflozin, Escita escitalopram